Funded startups/Ardego Therapeutics, Inc.

Ardego Therapeutics, Inc.

SEC filing

Biotechnology · Gaithersburg, MD

Form D on EDGAR

Amount raised$50Ksold at filing

Total offering$3M$3M still open

Investors in the raise1count reported to the SEC

FiledJun 3, 2026first sale May 13, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

BEVERLY SUE PACKARDExecutive Officer, Director

ETHAN EUGENE MANNExecutive Officer, Director

Executive officers, directors and promoters as listed on the Form D.